By Wolf Richter for WOLF STREET. Nvidia, the poster boy of the stock-market mania around Ai and semiconductors, plunged 9.5% in regular trading. In afterhours trading, it dropped another 2.6% to $105.40 a share, for a total drop […]
By Wolf Richter for WOLF STREET. The stock market hype and hoopla since December 2023 was focused on the Fed cutting rates, the Fed was going to cut six times, seven times in 2024, and then at Fed […]
Nvidia, after gaining $2.1 trillion YTD through July 10, gave up $418 billion or 12.6% since. Meta -13.6% in 5 days. Tesla should be kicked out of the Mag 7. By Wolf Richter for WOLF STREET. These numbers […]
Complete disaster. That’s the only way one can describe today’s 30Y auction, which many expected could be challenging after a mediocre 3Y and a subpar 10Y auction earlier this year, but nobody expected… this. The […]
Authored by Simon White, Bloomberg macro strategist, Bonds’ diminishing ability to act as a hedge for stocks jeopardizes the concept of the standard 60% equities, 40% bonds approach to portfolio design. A lack of viable […]
Among publicly-listed U.S. companies, the 25 worst stocks have lost shareholders a collective $1.2 trillion since 1926. Put another way, just 0.1% of all stocks have led to 14% of all cumulative losses in shareholder […]
It was only two weeks ago when, with the S&P about to break out to new 2023 highs, we noted that Bank of America ‘s client flows desk had declared retail capitulation (in the case […]
Chipmaker Nvidia (NVDA) grabbed the artificial intelligence spotlight this week with a raised outlook that sent Wall Street analysts into a tizzy. For investors homing in on AI stocks, the valuation of NVDA stock moves […]
While the “M” is the last part of the CAN SLIM trading methodology, it is by far the most important rule of timing when to buy stocks. IBD’s studies show that three out of four […]
S&P 500 medical stocks Cardinal Health (CAH), Vertex Pharmaceuticals (VRTX), Merck (MRK), Intuitive Surgical (ISRG) and Insulet (PODD) are in focus this week. Medical stocks are coming into favor again — with companies involved in […]
Copyright © 2025 | Sandstone Group